Studie van de bijzondere karakteristieken van portale hypertensie in Niet-Alcoholische Steatohepatitis and de rol hiervan in de ziekteprogressie. Universiteit Antwerpen
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most prevalent chronic liver disease worldwide. NAFLD-cirrhosis related morbidity represents a huge disease burden. No pharmacotherapy is currently approved, reflecting the poor understanding of NAFLD pathophysiology. Impairment of liver blood flow because of increased intrahepatic resistance is an early event that can contribute to disease progression by causing tissue hypoxia. Recent data also ...